Dein Bonus wartet – Hol Dir jetzt Dein finanzen.net ZERO-Depot und handle ohne Ordergebühr (zzgl. Spreads).

Synopsys Receives Final Regulatory Approval to Close Planned Divestitures of Synopsys Optical Solutions Group and Ansys PowerArtist

10.10.25 15:00 Uhr

Werte in diesem Artikel
Aktien

380,00 EUR -38,65 EUR -9,23%

SUNNYVALE, Calif., Oct. 10, 2025 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today announced that it has received approval from all necessary authorities to proceed with the planned, previously-announced divestitures of the Optical Solutions Group and PowerArtist businesses to Keysight Technologies, Inc.

Synopsys headquarters in Sunnyvale, Calif. (PRNewsfoto/Synopsys, Inc.)

These divestitures were determined by regulatory authorities to be a necessary step related to Synopsys' acquisition of Ansys, which successfully closed on July 17, 2025.  Synopsys expects to complete these divestitures on or about October 17, 2025.

The transactions are not material to Synopsys' financials, and terms of the agreements were not disclosed. Synopsys remains committed to a seamless transition for its employees, customers and partners. 

About Synopsys 
Synopsys, Inc. (Nasdaq: SNPS) is the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products. We deliver industry-leading silicon design, IP, simulation and analysis solutions, and design services. We partner closely with our customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com

© 2025 Synopsys, Inc. All rights reserved. Synopsys, Ansys, the Synopsys and Ansys logos, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html. Other company or product names may be trademarks of their respective owners.

INVESTOR CONTACT:
Tushar Jain
Synopsys, Inc.
650-584-5000
Synopsys-ir@synopsys.com 

EDITORIAL CONTACT:
Cara Walker
Synopsys, Inc.
650-584-5000
corp-pr@synopsys.com 

Forward-Looking Statements
This press release includes certain forward-looking statements regarding the expected timing of the closing of the divestitures and the related transition of the businesses to Keysight. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include but are not limited to, the failure to satisfy the conditions to the consummation of each of the proposed divestitures, and the risks more fully described in filings Synopsys makes with the SEC from time to time, including in the sections entitled "Risk Factors" in Synopsys' latest Annual Report on Form 10-K and in Synopsys' latest Quarterly Report on Form 10-Q. The information provided herein is as of. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

Synopsys (PRNewsfoto/Synopsys)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-receives-final-regulatory-approval-to-close-planned-divestitures-of-synopsys-optical-solutions-group-and-ansys-powerartist-302580754.html

SOURCE Synopsys, Inc.

In eigener Sache

Übrigens: Synopsys und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Synopsys

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Synopsys

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Synopsys Inc.

Wer­bung

Analysen zu Synopsys Inc.

DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
09.09.2015Synopsys HoldThe Benchmark Company
04.12.2008Synopsys UpgradeCitigroup Corp.
02.02.2007Synopsys neutralDA Davidson
31.01.2007Update Synopsys Inc.: NeutralDA Davidson
30.11.2006Synopsys holdDeutsche Securities
DatumRatingAnalyst
21.08.2008Synopsys DowngradeCitigroup Corp.
24.06.2005Synopsys underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen